Middle East Healthcare Company
4009.SRSAUHealthcare● Active
$33.00
+$0.60(+1.85%)
Market Cap$3.0B
P/E Ratio—
52W High$60.7
52W Low$28.66
Middle East Healthcare Company (4009.SR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 4009.SR · as of 2026-06-15
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $3.10B | $2.88B | $2.65B | $2.15B | $1.87B |
| Cost of Revenue | $1.94B | $1.77B | $1.65B | $1.47B | $1.26B |
| Gross Profit | $1.16B | $1.11B | $1.00B | $0.68B | $0.61B |
| Gross Margin %(computed) | 37.39% | 38.64% | 37.83% | 31.60% | 32.48% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.14B | $0.61B | $0.08B | $0.10B |
| Total Operating Expenses | $0.77B | $0.67B | $0.66B | $0.54B | $0.55B |
| Operating Income | $0.39B | $0.44B | $0.34B | $0.14B | $0.05B |
| Operating Margin %(computed) | 12.59% | 15.30% | 12.91% | 6.52% | 2.90% |
| Interest Income | $0.00B | ($0.00B) | $0.01B | $0.07B | $0.04B |
| Interest Expense | $0.20B | $0.22B | $0.16B | $0.07B | $0.04B |
| Income Before Tax | $0.33B | $0.31B | $0.20B | $0.08B | $0.02B |
| Income Tax Expense | $0.02B | $0.03B | $0.02B | $0.01B | $0.01B |
| Net Income | $0.30B | $0.28B | $0.18B | $0.08B | $0.01B |
| Net Margin %(computed) | 9.73% | 9.78% | 6.79% | 3.49% | 0.63% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.28 | $3.06 | $1.96 | $0.82 | $0.13 |
| Wtd Avg Shares | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B |
| EBITDA | $0.64B | $0.75B | $0.53B | $0.29B | $0.20B |
| EBITDA Margin %(computed) | 20.52% | 25.93% | 20.12% | 13.31% | 10.45% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Middle East Healthcare Company data
About Middle East Healthcare Company (4009.SR) Income Statement
Middle East Healthcare Company (4009.SR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, 4009.SR reported revenue of $3.10B, gross profit of $1.16B (gross margin 37.39%), and net income of $0.30B — a net profit margin of 9.73%.
Frequently asked questions
4009.SR · 4 questionsMiddle East Healthcare Company (4009.SR) reported revenue of $3.10B for 2025, up 7.6% year-over-year.
4009.SR revenue4009.SR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15